US Stem Cell Market Analysis
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 1,000.00
CD-ROM: US$ 900.00
The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem cells, researchers in the US are coming up with new outcomes that will make a paradigm shift in drug discovery and the medicine world. The country has witnessed some major achievements in the treatment of diseases by adopting stem cell technologies and products. Many such positive factors are contributing to the growth of the stem cell market in the US, which is likely to register a CAGR growth of around 45% during 2011-2013.
Better outcomes from the stem cell research can help the government and authorities in reducing escalating healthcare costs and developing new treatments. Moreover, stem cells can be used in finding innovative ways for drug discovery and developments. Some of the unique properties of stem cells are making them the favorite of the US physicians as well as patients. Though the debate over ethical issues still exists, the country is well recognizing many benefits and utilities of stem cell related therapies.
The government funding for stem cell research is one of the prominent issues that has had a huge impact on the market performance. Support from the National Institute of Health (NIH) and state associations, such as California Institute for Regenerative Medicine (CIRM) and New York State Stem Cell Science (NYSTEM) in conducting research and encouraging researchers has always backed the industry and will continue to do the same in future. The report provides an effective insight of this regard.
“US Stem Cell Market Analysis” is an outcome of an in-depth research and prudent analysis of the industry performance and current market trends that are affecting the US stem cell market. The report covers all the important aspects of the market along with the broad illustration of each one of them. The report will help clients in understanding the market dynamics and get an insight of the current and the future outlook of stem cells market in the US.
Multi-User License: US$ 1,400.00
Hard Copy: US$ 1,000.00
CD-ROM: US$ 900.00
The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem cells, researchers in the US are coming up with new outcomes that will make a paradigm shift in drug discovery and the medicine world. The country has witnessed some major achievements in the treatment of diseases by adopting stem cell technologies and products. Many such positive factors are contributing to the growth of the stem cell market in the US, which is likely to register a CAGR growth of around 45% during 2011-2013.
Better outcomes from the stem cell research can help the government and authorities in reducing escalating healthcare costs and developing new treatments. Moreover, stem cells can be used in finding innovative ways for drug discovery and developments. Some of the unique properties of stem cells are making them the favorite of the US physicians as well as patients. Though the debate over ethical issues still exists, the country is well recognizing many benefits and utilities of stem cell related therapies.
The government funding for stem cell research is one of the prominent issues that has had a huge impact on the market performance. Support from the National Institute of Health (NIH) and state associations, such as California Institute for Regenerative Medicine (CIRM) and New York State Stem Cell Science (NYSTEM) in conducting research and encouraging researchers has always backed the industry and will continue to do the same in future. The report provides an effective insight of this regard.
“US Stem Cell Market Analysis” is an outcome of an in-depth research and prudent analysis of the industry performance and current market trends that are affecting the US stem cell market. The report covers all the important aspects of the market along with the broad illustration of each one of them. The report will help clients in understanding the market dynamics and get an insight of the current and the future outlook of stem cells market in the US.
1. ANALYST VIEW
2. US STEM CELL MARKET OVERVIEW
2.1 Understanding Stem Cell
2.2 Stem Cell Market
3. US STEM CELL MARKET STRUCTURE
3.1 By Application
3.1.1 Stem Cells in Regenerative Medicine
3.1.2 Gene Therapy
3.1.3 Drug Development and Testing
3.2 By Product
3.2.1 Adult Stem Cell
3.2.2 Embryonic Stem Cell
3.3 By States
4. EMERGING AREAS FOR THERAPEUTIC APPLICATIONS
4.1 Spinal Cord Injury
4.2 Biologicals and Associated Hardware
4.3 Myocardial Infarction
4.4 Limb Ischemia
4.5 Cancer
5. KEY MARKET TRENDS
5.1 Cord Blood Banking Market
5.2 Potential Patient Population
5.3 Costly Treatments
6. CLINICAL TRIALS
7. INDUSTRY REGULATIONS
8. GOVERNMENT FUNDING
9. KEY PLAYERS
9.1 Cryo-Cell International
9.2 Cytori Therapeutics
9.3 StemCells Inc.
9.4 Aastrom Biosciences Inc
9.5 BrainStorm Cell Therapeutics
9.6 ThermoGenesis Corp
2. US STEM CELL MARKET OVERVIEW
2.1 Understanding Stem Cell
2.2 Stem Cell Market
3. US STEM CELL MARKET STRUCTURE
3.1 By Application
3.1.1 Stem Cells in Regenerative Medicine
3.1.2 Gene Therapy
3.1.3 Drug Development and Testing
3.2 By Product
3.2.1 Adult Stem Cell
3.2.2 Embryonic Stem Cell
3.3 By States
4. EMERGING AREAS FOR THERAPEUTIC APPLICATIONS
4.1 Spinal Cord Injury
4.2 Biologicals and Associated Hardware
4.3 Myocardial Infarction
4.4 Limb Ischemia
4.5 Cancer
5. KEY MARKET TRENDS
5.1 Cord Blood Banking Market
5.2 Potential Patient Population
5.3 Costly Treatments
6. CLINICAL TRIALS
7. INDUSTRY REGULATIONS
8. GOVERNMENT FUNDING
9. KEY PLAYERS
9.1 Cryo-Cell International
9.2 Cytori Therapeutics
9.3 StemCells Inc.
9.4 Aastrom Biosciences Inc
9.5 BrainStorm Cell Therapeutics
9.6 ThermoGenesis Corp
LIST OF FIGURES:
Figure 2-1: Stem Cell Therapy Development Process
Figure 2-2: Stem Cell Market (Million US$), 2008-2013
Figure 2-3: Forecast for Stem Cell Market by Region (%), 2013
Figure 3-1: Market for Stem Cells in Therapeutic Banking (Million US$), 2007-2013
Figure 3-2: Market for Stem Cells in Cellular Therapeutics (Million US$), 2007-2013
Figure 3-3: Stem Cell Product Market (Million US$), 2007-2013
Figure 3-4: Adult Stem Cell Product Market (Million US$), 2008-2013
Figure 3-5: California - Stem Cell Infrastructure Funding Break-up (%)
Figure 3-6: New York - Stem Cell Research by Disease (%)
Figure 4-1: Patients Suffering from Spinal Cord Injury (Million), 2006, 2008 & 2009
Figure 4-2: Patients Suffering from Myocardial Infarction (Million), 2006 & 2008
Figure 5-1: Cord Blood Bank Market (Million US$), 2007 & 2010
Figure 5-2: Cord Blood Inventory in Public and Private Banks (Million), H1 2008
Figure 6-1: Stem Cell Clinical Trials by Phase (%)
Figure 8-1: Forecast for NIH Spending on Stem Cell Research by Type (%), FY 2011
Figure 9-1: Share of Key Players in Stem Cell Therapeutics & Banking Market (2009)
Figure 2-1: Stem Cell Therapy Development Process
Figure 2-2: Stem Cell Market (Million US$), 2008-2013
Figure 2-3: Forecast for Stem Cell Market by Region (%), 2013
Figure 3-1: Market for Stem Cells in Therapeutic Banking (Million US$), 2007-2013
Figure 3-2: Market for Stem Cells in Cellular Therapeutics (Million US$), 2007-2013
Figure 3-3: Stem Cell Product Market (Million US$), 2007-2013
Figure 3-4: Adult Stem Cell Product Market (Million US$), 2008-2013
Figure 3-5: California - Stem Cell Infrastructure Funding Break-up (%)
Figure 3-6: New York - Stem Cell Research by Disease (%)
Figure 4-1: Patients Suffering from Spinal Cord Injury (Million), 2006, 2008 & 2009
Figure 4-2: Patients Suffering from Myocardial Infarction (Million), 2006 & 2008
Figure 5-1: Cord Blood Bank Market (Million US$), 2007 & 2010
Figure 5-2: Cord Blood Inventory in Public and Private Banks (Million), H1 2008
Figure 6-1: Stem Cell Clinical Trials by Phase (%)
Figure 8-1: Forecast for NIH Spending on Stem Cell Research by Type (%), FY 2011
Figure 9-1: Share of Key Players in Stem Cell Therapeutics & Banking Market (2009)
LIST OF TABLES:
Table 2-1: Global - Top Countries in Stem Cell Research
Table 4-1: Stem Cell Therapy Market Potential in Spinal Cord Injury (2009)
Table 4-2: Global - Top Countries in Cancer Stem Cell Research
Table 5-1: Number of Public Cord Blood Banks by States
Table 5-2: Number of Private Cord Blood Banks by States
Table 5-3: Potential Patient Population for Stem Cell Therapy by Medical Condition (Million)
Table 5-4: Annual Direct Expenditures for Selected Diseases (Billion US$)
Table 5-5: Stem Cell Therapy Cost Comparison to Leading Treatments (Million US$)
Table 6-1: Number of Stem Cell Clinical Trials by Key Disease Areas
Table 8-1: Funding of Stem Cell Research in Different States (2004-2007)
Table 8-2: NIH Funding for Stem Cell Research (Million US$), FY2008 to FY 2012
Table 9-1: Cytori Therapeutics - Strengths & Weaknesses
Table 9-2: Stem Cells Inc. - Strengths and Weaknesses
Table 9-3: Aastrom Biosciences Inc - Strengths and Weaknesses
Table 9-4: Brainstorm Cell Therapeutics - Strengths and Weaknesses
Table 9-5: Thermogenesis Corp - Strengths and Weaknesses
Table 2-1: Global - Top Countries in Stem Cell Research
Table 4-1: Stem Cell Therapy Market Potential in Spinal Cord Injury (2009)
Table 4-2: Global - Top Countries in Cancer Stem Cell Research
Table 5-1: Number of Public Cord Blood Banks by States
Table 5-2: Number of Private Cord Blood Banks by States
Table 5-3: Potential Patient Population for Stem Cell Therapy by Medical Condition (Million)
Table 5-4: Annual Direct Expenditures for Selected Diseases (Billion US$)
Table 5-5: Stem Cell Therapy Cost Comparison to Leading Treatments (Million US$)
Table 6-1: Number of Stem Cell Clinical Trials by Key Disease Areas
Table 8-1: Funding of Stem Cell Research in Different States (2004-2007)
Table 8-2: NIH Funding for Stem Cell Research (Million US$), FY2008 to FY 2012
Table 9-1: Cytori Therapeutics - Strengths & Weaknesses
Table 9-2: Stem Cells Inc. - Strengths and Weaknesses
Table 9-3: Aastrom Biosciences Inc - Strengths and Weaknesses
Table 9-4: Brainstorm Cell Therapeutics - Strengths and Weaknesses
Table 9-5: Thermogenesis Corp - Strengths and Weaknesses
